City Therapeutics raises $200M in IPO to advance next-gen RNAi drugs
The startup, co-founded by Alnylam's former CEO, will fund clinical trials for RNAi therapies targeting clotting, eye disease, and anemia.
Medicine & Biotech
Clinical AI, drug discovery, devices, and regulatory approvals.
New mRNA Flu Shot Hard to Find in First Season
Moderna's newly approved mRNA flu vaccine is available at only a limited number of locations this season, and experts say patients may need to search for it.
Bemotrizinol: First New U.S. Sunscreen Chemical in 25 Years
The FDA-approved chemical bemotrizinol offers broad-spectrum protection with minimal skin absorption and no white streaks, though its environmental impact remains uncertain.
Medicare Open Enrollment Brings 2027 Drug Cost Changes
New Part D caps, negotiated drug prices, and a one-time Part B rebate define the 2027 Medicare season.
SFDI Imaging Shows Promise for Assessing Scleroderma Skin Fibrosis
A noninvasive visible-light imaging method matched standard clinical scoring and biopsy results in scleroderma patients, pointing to a new way to monitor skin disease.
Hospital Workers Turn to Social Media for Humor and Grievances
A MedPage Today roundup shows clinicians using social media to mock night shift fears, complain about fax-based prior authorization, and share small practical wins.
Gram-Positive Rods in a Butcher's Hand: What's the Diagnosis?
A 53-year-old butcher's hand infection after a meat-processing cut highlights the value of occupational history and gram stain in diagnosing zoonotic skin infections.
Merck and Moderna map next steps after melanoma vaccine win
The partners are prioritizing tumor types where Keytruda already works as they seek to expand their personalized mRNA cancer vaccine beyond melanoma.
DOJ expands health care fraud enforcement with new self-disclosure policy
The Department of Justice is broadening its fraud investigations to target corporate health care wrongdoing, using AI and streamlined self-disclosure to encourage companies to come forward.
Rosarium Health Partners With Anthem Medi-Cal for Home Safety Mods
The collaboration aims to deliver home safety modifications to eligible Anthem Medi-Cal members through Rosarium Health's platform.
Plastic Surgeons Condemn 'The Swan' Makeover Show in New Documentary
A new documentary revisits the 2000s reality show 'The Swan,' with plastic surgeons calling out its unsafe and unethical practices.
Tegoprazan Cuts Heartburn Frequency in Non-Erosive Reflux Disease Trial
A phase III trial found that once-daily tegoprazan significantly increased heartburn-free days in patients with non-erosive reflux disease, supporting a new treatment option beyond PPIs.
COVID Paper Retracted; FDA Rare Disease Push and Bladder Cancer Approval
MedPage Today's roundup brings together retracted research, FDA regulatory actions, and device-safety findings.
Small Cancer Cells with Extra Chromosomes Are Surprisingly Aggressive
New research shows that unusually small cancer cells carrying extra chromosomes grow faster, spread more readily, and resist treatment, which may help explain why some tumors are so dangerous.
Rush and Endeavor propose merger to create Illinois health giant
The proposed deal would combine 12 hospitals and 400 clinics into one of Illinois's largest health systems, pending regulatory approval.
HHS Moves to Let Pharmacies Compound Unapproved Peptides
The Trump administration has sent a policy to the White House that would use enforcement discretion to allow compounding pharmacies to sell popular but unproven peptide injections.
AMA issues governance framework for clinical AI agents
The American Medical Association's new framework sets four questions to guide safe use of autonomous AI in patient care.
Reinventing Primary Care: From Episodic to Continuous
A MedCity News analysis argues that primary care must shift from episodic encounters to continuous engagement.